Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to ...

Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.

The stock's fall snapped a four-day winning streak.

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...